JACKSON SQUARE CAPITAL, LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1812178 SAN FRANCISCO, CA

Position in CRVS

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$932,998

+$441,946 QoQ

Shares Held

63,773

0.0% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACKSON SQUARE CAPITAL, LLC holds $1,340,179 across 2 Biotechnology names. CRVS ranks #1 (69.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	CRVS	Corvus Pharmaceuticals, Inc. This page	63,773	$932,998
2	REGN	Regeneron Pharmaceuticals, Inc.	527	$407,181

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$932,998	63,773	0.0%	Shares	Sole	2026-04-13
2025-12-31	$491,052	63,773	0.0%	Shares	Sole	2026-01-21
2025-09-30	$470,007	63,773	0.0%	Shares	Sole	2025-10-09
2025-06-30	$255,092	63,773	0.0%	Shares	Sole	2025-07-10
2025-03-31	$202,798	63,773	0.0%	Shares	Sole	2025-04-16
2024-12-31	$341,185	63,773	0.0%	Shares	Sole	2025-01-15
2024-09-30	$336,721	63,773	0.0%	Shares	Sole	2024-10-31
2024-06-30	$116,066	63,773	0.0%	Shares	Sole	2024-08-05
2024-03-31	$113,515	63,773	0.0%	Shares	Sole	2024-04-16
2023-12-31	$112,240	63,773	0.0%	Shares	Sole	2024-01-09
2023-09-30	$93,108	63,773	0.0%	Shares	Sole	2023-10-25
2023-06-30	$146,040	63,773	0.0%	Shares	Sole	2023-07-28
2023-03-31	$58,033	63,773	0.0%	Shares	Sole	2023-04-21
2022-12-31	$54,207	63,773	0.0%	Shares	Sole	2023-01-23
2022-09-30	$52,230	63,773	0.0%	Shares	Sole	2022-10-13
2022-06-30	$63,135	63,773	0.0%	Shares	Sole	2022-07-25
2022-03-31	$104,587	63,773	—	Shares	Sole	2022-04-20
No filing history on record for this holder in this stock.